Keyword: Lundbeck

Research & Innovation

Artificial Intelligence for New Drug Design

16.09.2021 -

Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies.


Lundbeck to Acquire Prexton Therapeutics

21.03.2018 - Danish drugmaker Lundbeck has announced plans to buy Swiss drug developer Prexton Therapeutics in a deal worth up to €905 million. The deal would give Lundbeck global rights to...


iBIO and iBIO Institute Boards Elect Andy Hull and Linda Friedman as 2014 Chairs

24.01.2014 - The Illinois Biotechnology Industry Organization (iBIO) today announced the election of Andy Hull as chairman of the iBIO Board of Directors, and the election of Linda Friedman, as...


China to Launch Fresh Pharmaceutical Bribery Probe

15.08.2013 - China is intensifying its investigation into rampant bribery in the pharmaceutical and medical services sector with a fresh three-month probe slated to begin on Thursday, the...


Lundbeck Suffers Q2 Loss

08.08.2013 - Danish pharmaceuticals group Lundbeck posted a bigger-than-expected operating loss in the second quarter, hit by an EU fine for breaking competition law and cheap competition after...


Lundbeck, Merck KGaA and Others Fined for Blocking Rival Drugs

20.06.2013 - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of €146 million ($195 million) for blocking the supply of a cheaper anti-depressant to...


EU to Fine Lundbeck, Others for Blocking Generic Drugs

03.06.2013 - A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said...


Drugmakers, Academics Pool R&D in $265 Million EU Project

07.02.2013 - Seven European drugmakers are to pool their research efforts with academic scientists and smaller companies in a new €196 million ($265 million) project designed to find tomorrow's...